We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's What Key Metrics Tell Us About The Pennant Group, Inc. (PNTG) Q2 Earnings
Read MoreHide Full Article
The Pennant Group, Inc. (PNTG - Free Report) reported $132.28 million in revenue for the quarter ended June 2023, representing a year-over-year increase of 13.7%. EPS of $0.18 for the same period compares to $0.14 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $125.99 million, representing a surprise of +5.00%. The company delivered an EPS surprise of +12.50%, with the consensus EPS estimate being $0.16.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how The Pennant Group, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenue- Total home health and hospice services: $95.02 million versus the two-analyst average estimate of $92.17 million. The reported number represents a year-over-year change of +11.3%.
Revenue- Senior living services: $37.26 million versus the two-analyst average estimate of $35.39 million. The reported number represents a year-over-year change of +20.3%.
Revenue- Home health and hospice services- Home care and other: $6.05 million versus $6.03 million estimated by two analysts on average.
Revenue- Home health and hospice services- Hospice: $46.56 million versus $43.77 million estimated by two analysts on average.
Revenue- Home health and hospice services- Home health: $42.41 million versus the two-analyst average estimate of $42.37 million.
Shares of The Pennant Group, Inc. have returned -2.3% over the past month versus the Zacks S&P 500 composite's +2.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's What Key Metrics Tell Us About The Pennant Group, Inc. (PNTG) Q2 Earnings
The Pennant Group, Inc. (PNTG - Free Report) reported $132.28 million in revenue for the quarter ended June 2023, representing a year-over-year increase of 13.7%. EPS of $0.18 for the same period compares to $0.14 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $125.99 million, representing a surprise of +5.00%. The company delivered an EPS surprise of +12.50%, with the consensus EPS estimate being $0.16.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how The Pennant Group, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Total home health and hospice services: $95.02 million versus the two-analyst average estimate of $92.17 million. The reported number represents a year-over-year change of +11.3%.
- Revenue- Senior living services: $37.26 million versus the two-analyst average estimate of $35.39 million. The reported number represents a year-over-year change of +20.3%.
- Revenue- Home health and hospice services- Home care and other: $6.05 million versus $6.03 million estimated by two analysts on average.
- Revenue- Home health and hospice services- Hospice: $46.56 million versus $43.77 million estimated by two analysts on average.
- Revenue- Home health and hospice services- Home health: $42.41 million versus the two-analyst average estimate of $42.37 million.
View all Key Company Metrics for The Pennant Group, Inc. here>>>Shares of The Pennant Group, Inc. have returned -2.3% over the past month versus the Zacks S&P 500 composite's +2.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.